Our reporter Pei Hong, correspondent Sudan
“Traditional Chinese medicine pieces, due to objective differences in natural resources and primary processing product forms, have always had inconsistent quality standards and poor drug quality. Control, chronic diseases with unstable drug performance. With traditional decoction methods, only 10-30% of the medicinal ingredients in traditional Chinese medicine pieces can be effectively utilized. These factors have become bottlenecks restricting the development of the traditional Chinese medicine industry. "Zhongzhi Pharmaceutical Group (hereinafter referred to as "Zhongzhi Pharmaceutical Group") Cheng Jinle, chief engineer of Zhongzhi Pharmaceutical, introduced to the reporter of China Intellectual Property News. In response to these shortcomings, Zhongzhi Pharmaceutical has actively explored in recent years, trying to achieve innovative development of traditional Chinese medicine pieces with modern technology, and has created wall-breaking traditional Chinese medicine pieces represented by "Cao Jinghua", which has brought major changes to the traditional Chinese medicine industry. .
Founded in 1993, Zhongzhi Pharmaceutical is a technology-based pharmaceutical enterprise integrating pharmaceutical research, production and sales. Over the years, the company has adhered to an innovation-driven strategy and attached great importance to technological innovation. It has now established 15 national, provincial and municipal science and technology innovation platforms, developed a number of specialty products with independent intellectual property rights, and created a new category of traditional Chinese medicine pieces. , which has effectively promoted the transformation and upgrading of the traditional Chinese medicine industry. In Cheng Jinle's view, Zhongzhi Pharmaceutical is not only the inventor of the technology of broken-down traditional Chinese medicine pieces, but also the pioneer of new types of traditional Chinese medicine pieces.
Innovative technology makes traditional Chinese medicine shine
It is understood that Zhongzhi Pharmaceutical began to research the technology of broken-walled Chinese medicine pieces in 2003. After more than 10 years of research and exploration, it finally successfully developed The two core technologies of traditional Chinese medicine wall breaking and additive-free shaping have been developed. On this basis, Zhongzhi Pharmaceutical has built a number of production lines for in-depth and fine processing of Chinese herbal medicine stems, branches, powders and Chinese herbal pieces, using standardized production techniques and modern management processes to process Chinese medicines. At present, Zhongzhi Pharmaceutical has developed three major product series of traditional Chinese medicine broken pieces, Chinese patent medicines and health foods with independent intellectual property rights, becoming a banner for the innovation of traditional Chinese medicine in my country.
"Break its shape and preserve its marrow", by using traditional Chinese medicine ultra-fine grinding technology to break the cell wall of Chinese medicinal materials to make wall-breaking powder, and then use additive-free excipient technology to make granules, which can be consumed directly with water Brewing is quick and easy. Cheng Jinle introduced that by breaking the cell wall to form drug powder, the active ingredients of traditional Chinese medicine are completely released, which solves the problem of the efficacy of traditional Chinese medicine. On the basis of powder, it is made into granules through additive-free excipient technology, which can effectively overcome the shortcomings of powdered pharmaceuticals that are easy to agglomerate and oxidize, and solve the problem of drug stability, thereby achieving controllable quality, uniform material, and metered Accurate modern Chinese medicine products.
Not only that, Zhongzhi Pharmaceutical has been committed to the modern transformation of the traditional Chinese medicine industry, attaches great importance to technological innovation, and continues to increase investment in research and development. In 2017 alone, the company’s investment in research and development reached 34.5 million yuan, which is It is rare among traditional Chinese medicine companies. At the same time, Zhongzhi Pharmaceutical, as one of the earliest enterprises in Guangdong Province to carry out industry-university-research cooperation, has successively cooperated with scientific research institutions and universities such as Guangzhou University of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Macau University of Science and Technology. In-depth cooperation. In addition, Zhongzhi Pharmaceutical has also taken the lead in establishing the "Technological Innovation Alliance for Traditional Chinese Medicine Broken Pieces Industry", and continues to develop traditional Chinese medicine resources and Production quality control, drug safety and stability research, and research on international and domestic quality standards for traditional Chinese medicine have established a firm foothold in the industry.
Focus on layout and intellectual property rights highlight the value
Data show that the market size of traditional Chinese medicine pieces reached 25.6 billion yuan in 2017, a year-on-year increase of 10.5%, and the sales scale in 2018 is expected to exceed 27 billion yuan. Aiming at the huge market, Zhongzhi Pharmaceutical launched the "Cao Jinghua" series of products. Since its launch in 2012, this product has been very popular with customers, with a compound growth rate of 73.96. It is far ahead in the market of traditional Chinese medicine pieces and has become the flagship product and representative brand of Zhongzhi Pharmaceutical. The people of Zhongzhi Pharmaceutical clearly realize that protecting independent innovation results will help maintain market leadership.
Therefore, leading the development of enterprises with core technologies is the top priority of Zhongzhi Pharmaceutical at this stage.
“Zhongzhi Pharmaceutical has initially formed an intellectual property work system that is compatible with the company’s scientific research innovation and its own business development, established a dedicated intellectual property management team, and hired external legal consultants to assist the company in related work. In recent years, the company has formulated an intellectual property management system and reward system, regularly conducted patent knowledge training, evaluated scientific research and innovation results, actively conducted patent mining and patent applications, gradually improved the patent layout, and initially established an intellectual property early warning and risk prevention mechanism. It provides strong protection for the company's independently developed core technologies and also plays a positive role in promoting the brand building of high-tech products such as 'Cao Jinghua'," said Cheng Jinle.
At present, Zhongzhi Pharmaceutical has submitted patent applications for a number of core technologies such as Chinese medicine broken pieces, Chinese medicine fingerprint quality control and secondary development of Chinese patent medicines. Chinese medicine products, production processes, quality control , product packaging and other dimensions, and try to gradually build a patent pool based on authorized patents, in order to fully protect the company's innovative achievements and lay the foundation for future patent operations in the field of traditional Chinese medicine. Cheng Jinle introduced that Zhongzhi Pharmaceutical has submitted more than 80 patent applications for the technology of traditional Chinese medicine wall-breaking pieces, and the patent application areas include mainland China, Hong Kong and Macao Special Administrative Region, and Taiwan. The company was recognized as a "National Intellectual Property Advantage Enterprise" in 2017, and won one 19th China Patent Excellence Award, one Zhongshan Patent Gold Award, and two Zhongshan Patent Excellence Awards.
"Zhongzhi Pharmaceutical will continue to hold high the banner of technological innovation, continue to lead the modern transformation of the traditional Chinese medicine decoction piece industry, strive to promote the establishment of national and international standards for traditional Chinese medicine decoction pieces, continue to increase investment in research and development, and highly Pay attention to intellectual property rights and continuously improve patent layout." Cheng Jinle said that in the future, Zhongzhi Pharmaceutical will further increase its efforts in overseas patent layout to protect and provide assistance for the company to actively explore overseas markets.
Comments
As a technology-based small and medium-sized enterprise in the pharmaceutical field, Zhongzhi Pharmaceutical aims at development goals, using "Cao Jinghua" as the core and entry point of research and development, and continuously carries out technical research. , finally achieved a major breakthrough, created a new category of traditional Chinese medicine pieces, and realized the standardization of "non-standard products", winning the best opportunity for rapid development. Zhongzhi Pharmaceutical has successfully embarked on a path of modernization and transformation of traditional Chinese medicine enterprises, which can be summarized as follows: relying on independent innovation, mastering core technologies, paying attention to intellectual property rights, building technical barriers, and accelerating patent layout. Its successful development experience can serve as a reference for other companies in the industry. (Sudan)
September 26, 2018 Pei Hong Sudan